Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes

E Nisoli, C Tonello, M Landi and MO Carruba

Department of Pharmacology, Chemotherapy, and Medical Toxicology, School of Medicine, Milan University, Italy.

The SS-enantiomer 3-(2-ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahy dronaphth- 1-ylaminol]-(2S)-2-propanol oxalate (SR 59230A) is proposed to be the first beta 3-adrenergic receptor antagonist. The present work shows that SR 59230A, unlike its inactive RR-enantiomer (SR 59483), antagonized a typical beta 3-adrenergic response in vitro, i.e., SR 58611A, the ethyl-[(7s)-7-[[(2R)-2-(3- chlorophenyl)-2- hydroxethyl]amino]-5,6,7,8-tetrahydronaphth- 2- yl]oxyacetate hydrochloride- or (-)-4-(3-t-butylamino-2-hydroxypropoxy)benzimidazol-2- one (CGP 12177)-stimulated synthesis of cAMP in rat brown adipose tissue membranes, with pKB values of 8.87 +/- 0.12 and 8.20 +/- 0.15. In addition, SR 59230A had no antagonistic effect on forskolin-induced cAMP accumulation in rat interscapular brown adipose tissue. SR 59230A, in contrast to the selective beta 1- and beta 2-adrenoceptor antagonists (+/-)[2-(3-carbamoyl-4-hydroxyphenoxy)-ethylamino]- 3-[4(1- methyl-4-trifluoromethyl-2-imidazolyl)-phenoxy]-2 propanol and erythro- (+/-)-1-(7-methylindan-4-yloxy)-3-isopropylaminob utan- 2-ol- hydrochloride did not counteract the cAMP production induced by (-)- isoprenaline or norepinephrine (NE) in rat brain areas rich in beta 1- or beta 2-adrenoceptors, such as frontal cortex and cerebellum. Moreover, in proliferating brown fat cells, in which the beta 1- adrenoceptor is the only beta-adrenergic subtype coupled to cAMP production, SR 59230A did not modify the production of cAMP induced by NE, whereas CGP 12177 did. In confluent brown fat cells, in which the beta 3-adrenoceptor is the functional beta-adrenergic subtype coupled to adenylyl cyclase, SR 59230A antagonized the NE-induced cAMP accumulation and glycerol release without affecting their basal values, whereas CGP 12177, which per se stimulated cAMP accumulation and glycerol release, did not change the NE-induced increase of either parameter. Finally, SR 59230A concentration-dependently counteracted the NE-stimulated synthesis of uncoupling protein gene in confluent brown fat cells, which is considered mainly a result of selective stimulation of beta 3-adrenoceptors. These results provide evidence that the new selective beta 3-adrenoceptor antagonist can contribute considerably to functional characterization of the beta 3-adrenoceptors.

Volume 49, Issue 1, pp. 7-14, 01/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. S. Hutchinson, M. Sato, B. A. Evans, A. Christopoulos, and R. J. Summers Evidence for Pleiotropic Signaling at the Mouse {beta}3-Adrenoceptor Revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol Oxalate] J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1064 - 1074. [Abstract] [Full Text] [PDF]

				V. Leblais, F. Pourageaud, M. D. Ivorra, C. Guibert, R. Marthan, and B. Muller Role of {alpha}-Adrenergic Receptors in the Effect of the {beta}-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 137 - 145. [Abstract] [Full Text]

				B. CANNON and J. NEDERGAARD Brown Adipose Tissue: Function and Physiological Significance Physiol Rev, January 1, 2004; 84(1): 277 - 359. [Abstract] [Full Text] [PDF]

				D. N. K. Sarma, K. Banwait, A. Basak, A. J. DiMarino, and S. Rattan Inhibitory Effect of beta 3-Adrenoceptor Agonist in Lower Esophageal Sphincter Smooth Muscle: In Vitro Studies J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 48 - 55. [Abstract] [Full Text] [PDF]

				M. Pelat, P. Verwaerde, J. Galitzky, M. Lafontan, M. Berlan, J.-M. Senard, and J.-L. Montastruc High Isoproterenol Doses Are Required to Activate beta 3-Adrenoceptor-Mediated Functions in Dogs J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 246 - 253. [Abstract] [Full Text] [PDF]

				S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]

				G. Bronnikov, T. Bengtsson, L. Kramarova, V. Golozoubova, B. Cannon, and J. Nedergaard {beta}1 to {beta}3 Switch in Control of Cyclic Adenosine Monophosphate during Brown Adipocyte Development Explains Distinct {beta}-Adrenoceptor Subtype Mediation of Proliferation and Differentiation Endocrinology, September 1, 1999; 140(9): 4185 - 4197. [Abstract] [Full Text]

				M. R. Candelore, L. Deng, L. Tota, X.-M. Guan, A. Amend, Y. Liu, R. Newbold, M. A. Cascieri, and A. E. Weber Potent and Selective Human beta 3-Adrenergic Receptor Antagonists J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 649 - 655. [Abstract] [Full Text]

				J. Zhao, B. Cannon, and J. Nedergaard alpha 1-Adrenergic Stimulation Potentiates the Thermogenic Action of beta 3-Adrenoreceptor-generated cAMP in Brown Fat Cells J. Biol. Chem., December 26, 1997; 272(52): 32847 - 32856. [Abstract] [Full Text] [PDF]

				E. Nisoli, C. Tonello, L. Briscini, and M. O. Carruba Inducible Nitric Oxide Synthase in Rat Brown Adipocytes: Implications for Blood Flow to Brown Adipose Tissue Endocrinology, February 1, 1997; 138(2): 676 - 682. [Abstract] [Full Text] [PDF]

				S. P. Commins, P. M. Watson, N. Levin, R. J. Beiler, and T. W. Gettys Central Leptin Regulates the UCP1 and ob Genes in Brown and White Adipose Tissue via Different beta -Adrenoceptor Subtypes J. Biol. Chem., October 13, 2000; 275(42): 33059 - 33067. [Abstract] [Full Text] [PDF]

				J. M. Lindquist, J. M. Fredriksson, S. Rehnmark, B. Cannon, and J. Nedergaard beta 3- and alpha 1-Adrenergic Erk1/2 Activation Is Src- but Not Gi-mediated in Brown Adipocytes J. Biol. Chem., July 21, 2000; 275(30): 22670 - 22677. [Abstract] [Full Text] [PDF]